In the pipeline: diabetes care improvements
As 2016 gets underway, improvements in diabetes health management are expected to progress. Here are some of the noteworthy trends to watch.
Read More
ICD-10 impact on reimbursement, payers, and providers
How did the ICD-10 transition impact health systems and health plans? Here, those in the field, weigh in.
J&J’s antibiotic faces $800M lawsuit
Johnson & Johnson faces $800 million racketeering lawsuit over its antibiotic, Levaquin.
Diabetes drug Tresiba to make billions
Tresiba, the long-acting insulin that just came on the market in January, stands to net Novo Nordisk billions of dollars.
First chemo drug to show survival benefit for liposarcoma passes
FDA recently approved (Halaven, Eisai), the first chemotherapy drug to demonstrate survival benefit for liposarcoma that cannot be removed by surgery or is advanced.
CMS proposes network adequacy rules
Rule would expand standards health plans must meet to be certified as qualified health plans
Study: Link between CS score and costs
Prime Therapeutics has studied the costs and clinical events relationship among their members using a controlled substances (CS) score algorithm that identifies potential overuse/abuse of opioids/controlled substances.
Survey: More providers embrace remote health monitoring
Population health initiatives are driving rapid adoption of mobile remote patient monitoring solutions, according to a new report.
Politics and Policy Survey
We want to know what you think about the top policy issues facing the industry. Please take our quick survey. You’ll be entered to win a $200 Visa gift card.
Seven healthcare industry trends to watch
One month into 2016, it’s clear that this will be a year of massive change for the managed care industry. Here are seven predictions for some of the key issues that will emerge, intensify, or be resolved by the end of this year.
Don’t underrate power of provider-sponsored MA plans
Nearly 60% of new MA plans are sponsored by providers, according to new Avalere analysis.
Five ways technology can increase patient compliance
As technology advances, it is transforming healthcare in ways never thought possible
Runaway pharma costs tackled in new Medicaid plan
N.Y. Gov. Andrew Cuomo proposes a budget provision that would call for capping prices on some drugs and requiring drug companies to provide information about their costs.
Five tech trends that will change the healthcare industry
New technology is changing how payers, providers, and patients interact. Stay ahead of the curve by monitoring these technology changes.
Hearing ups pressure on drugmakers’ prices
When the House Committee on Oversight and Government Reform met on January 26, legislators took a closer look at price hikes from companies such as Valeant Pharmaceuticals and Turing Pharmaceuticals.
Effective population health management involves more than just data
A common question facing healthcare executives is how to get started with population health management. Here are steps and strategies critical to success.
Centene data breach underscores escalating problem
Another health insurer is facing a major healthcare data breach. Here’s how cybersecurity experts are reacting.
High-dose insulin pen hits market
Eli Lilly & Company finally releases a high-dose insulin pen, which will help cut down on medication errors associated with the U-100 Humulin insulin pens.
Four cybersecurity mistakes health plans make
To help ensure you are doing all you can to prevent a security breach, we asked the experts to weigh in. Here they identify four of the biggest mistakes health plans are making.
Opinion: Healthcare industry predictions for 2016
In this commentary, an industry insider shares his 2016 predictions for healthcare. Do you agree?
Study: Impact of pay-for-performance incentives in ACOs
A new study of a pediatric ACO serving approximately 300,000 Medicaid-eligible children in Ohio evaluated whether financial incentives influence physician behavior.
Nine ways MCOs can cut administrative costs
For decades, administrative costs for health plans have stalled. Today’s healthcare market is full of opportunities to trim the fat.
Survey: Health execs not jumping on precision medicine
The precision medicine uptake is not as fast as predicted in healthcare organizations, but academic medical centers are jumping on board faster than others.
Cosentyx gets thumbs up for 2 new indications
FDA has approved secukinumab (Cosentyx, Novartis) for the treatment of adult patients with active ankylosing spondylitis and active psoriatic arthritis.
Employers aim to curb specialty drug costs
A new survey reveals what employers' medical plans are doing to rein in specialty drug cost and utilization.
More young white males dying from drug overdoses
It is young white males who are dying from drug overdoses in the U.S., according to a New York Times analysis of death certificates.
Compounding pharmacy recalls medications
Abbott's Compounding Pharmacy in Berkeley, Calif., is voluntarily recalling all unexpired lots of sterile compounded products because of lack of sterility assurance.
Health execs predict top 2016 challenges
We asked the Managed Healthcare Executive editorial advisory board to predict the biggest challenge healthcare executives will face this year. Here's what they said.
FDA approves new indication for Hib vaccine
FDA has approved an expanded age indication for Hib vaccine (Hiberix, GlaxoSmithKine).
Six new skills needed by healthcare executives
As the healthcare industry changes, health plan executives must master new skills.
